• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HKR3通过抑制肝癌细胞系中的hTERT来调节细胞周期。

HKR3 regulates cell cycle through the inhibition of hTERT in hepatocellular carcinoma cell lines.

作者信息

Choi Sung Hoon, Cho Kyung Joo, Yun Sung Ho, Jin Bora, Lee Ha Young, Ro Simon W, Kim Do Young, Ahn Sang Hoon, Han Kwang-Hyub, Park Jun Yong

机构信息

Yonsei Liver Center, Yonsei University College of Medicine, Seoul, Republic of Korea.

BK21 plus project for medical science, Yonsei University College of Medicine, Seoul, Republic of Korea.

出版信息

J Cancer. 2020 Feb 10;11(9):2442-2452. doi: 10.7150/jca.39380. eCollection 2020.

DOI:10.7150/jca.39380
PMID:32201515
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7066026/
Abstract

Hepatocellular carcinoma is a malignant disease with improved hepatic regeneration and survival, and is activated by human telomere transferase (hTERT). hTERT is expressed during early fetal development and switched off in most adult tissues, but it becomes reactivated in HCC. The exact mechanism regulating these expression changes remains unknown during HCC progress. We evaluated the relationship between hTERT expression and human kruppel-related 3 (HKR3) and cell cycle-related factors in HCC cell lines. Following transfection for hTERT knockdown and HKR3 overexpression, proteomic and transcriptomic analyses related to hTERT were performed using liquid chromatography/mass spectrometry (LC/MS) and RNA sequencing (RNAseq) in HCC cell lines. The expression levels of hTERT, HKR3, and cell cycle-related factors were measured using western blotting, and tumor growth were evaluated via cell proliferation and cell cycle assays. Transcriptomic and proteomic analyses showed that HKR3, hTERT and cyclin-dependent kinase inhibitor 2A (CDKN2A) were correlated. Up-regulation of HKR3 expression decreased hTERT and cyclin activation and suppressed the G1/S phase of the cell cycle through CDKN2A activation. Our results suggest that HKR3 induced regulation of cell cycle through hTERT inhibition and CDKN2A activation. Our results will facilitate further exploration of the pathways regulating human telomerase activity in HCC cell lines.

摘要

肝细胞癌是一种具有改善的肝再生和生存率的恶性疾病,由人端粒转移酶(hTERT)激活。hTERT在胎儿早期发育过程中表达,在大多数成人组织中关闭,但在肝癌中重新激活。在肝癌进展过程中,调节这些表达变化的确切机制仍不清楚。我们评估了hTERT表达与人克鲁ppel相关3(HKR3)和肝癌细胞系中细胞周期相关因子之间的关系。在转染hTERT敲低和HKR3过表达后,使用液相色谱/质谱(LC/MS)和RNA测序(RNAseq)在肝癌细胞系中进行了与hTERT相关的蛋白质组学和转录组学分析。使用蛋白质印迹法测量hTERT、HKR3和细胞周期相关因子的表达水平,并通过细胞增殖和细胞周期测定评估肿瘤生长。转录组学和蛋白质组学分析表明,HKR3、hTERT和细胞周期蛋白依赖性激酶抑制剂2A(CDKN2A)相关。HKR3表达上调降低了hTERT和细胞周期蛋白的激活,并通过激活CDKN2A抑制细胞周期的G1/S期。我们的结果表明,HKR3通过抑制hTERT和激活CDKN2A诱导细胞周期调控。我们的结果将有助于进一步探索肝癌细胞系中调节人端粒酶活性的途径。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1378/7066026/90c78438045f/jcav11p2442g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1378/7066026/117848169cb6/jcav11p2442g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1378/7066026/3b845b88a71d/jcav11p2442g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1378/7066026/0df46293dcd7/jcav11p2442g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1378/7066026/0e67dcca269b/jcav11p2442g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1378/7066026/d45bca75fb27/jcav11p2442g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1378/7066026/90c78438045f/jcav11p2442g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1378/7066026/117848169cb6/jcav11p2442g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1378/7066026/3b845b88a71d/jcav11p2442g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1378/7066026/0df46293dcd7/jcav11p2442g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1378/7066026/0e67dcca269b/jcav11p2442g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1378/7066026/d45bca75fb27/jcav11p2442g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1378/7066026/90c78438045f/jcav11p2442g006.jpg

相似文献

1
HKR3 regulates cell cycle through the inhibition of hTERT in hepatocellular carcinoma cell lines.HKR3通过抑制肝癌细胞系中的hTERT来调节细胞周期。
J Cancer. 2020 Feb 10;11(9):2442-2452. doi: 10.7150/jca.39380. eCollection 2020.
2
RBFOX3 Promotes Tumor Growth and Progression via hTERT Signaling and Predicts a Poor Prognosis in Hepatocellular Carcinoma.RBFOX3通过hTERT信号通路促进肿瘤生长和进展,并预测肝细胞癌预后不良。
Theranostics. 2017 Jul 22;7(12):3138-3154. doi: 10.7150/thno.19506. eCollection 2017.
3
Telomerase activity in human hepatocellular carcinoma: parallel correlation with human telomerase reverse transcriptase (hTERT) mRNA isoform expression but not with cell cycle modulators or c-Myc expression.人肝细胞癌中的端粒酶活性:与人类端粒酶逆转录酶(hTERT)mRNA 亚型表达呈平行相关性,但与细胞周期调节因子或 c-Myc 表达无关。
Eur J Surg Oncol. 2002 Apr;28(3):225-34. doi: 10.1053/ejso.2001.1237.
4
Hepatitis B virus protein preS2 potentially promotes HCC development via its transcriptional activation of hTERT.乙肝病毒前S2蛋白可能通过对端粒酶逆转录酶的转录激活作用促进肝癌发展。
Gut. 2009 Nov;58(11):1528-37. doi: 10.1136/gut.2008.174029. Epub 2009 Aug 2.
5
Effect of newly identified hTERT-interacting proteins on telomerase activity.新鉴定的 hTERT 相互作用蛋白对端粒酶活性的影响。
Acta Biochim Biophys Sin (Shanghai). 2013 Aug;45(8):674-82. doi: 10.1093/abbs/gmt056. Epub 2013 May 23.
6
BPTF promotes hepatocellular carcinoma growth by modulating hTERT signaling and cancer stem cell traits.BPTF 通过调节端粒酶逆转录酶信号和癌症干细胞特征促进肝癌生长。
Redox Biol. 2019 Jan;20:427-441. doi: 10.1016/j.redox.2018.10.018. Epub 2018 Oct 25.
7
Human Kruppel-related 3 (HKR3) is a novel transcription activator of alternate reading frame (ARF) gene.人 Kruppel 相关蛋白 3(HKR3)是一种新型的交替阅读框(ARF)基因转录激活因子。
J Biol Chem. 2014 Feb 14;289(7):4018-31. doi: 10.1074/jbc.M113.526855. Epub 2014 Jan 1.
8
Telomerase and c-myc expression in hepatocellular carcinomas.端粒酶与c-myc在肝细胞癌中的表达
Eur J Surg Oncol. 2004 May;30(4):384-90. doi: 10.1016/j.ejso.2004.01.003.
9
Atorvastatin-induced senescence of hepatocellular carcinoma is mediated by downregulation of hTERT through the suppression of the IL-6/STAT3 pathway.阿托伐他汀诱导的肝癌细胞衰老通过抑制IL-6/STAT3信号通路下调hTERT来介导。
Cell Death Discov. 2020 Mar 30;6:17. doi: 10.1038/s41420-020-0252-9. eCollection 2020.
10
RNA interference-mediated hTERT inhibition enhances TRAIL-induced apoptosis in resistant hepatocellular carcinoma cells.RNA 干扰介导的端粒酶逆转录酶抑制增强 TRAIL 诱导耐药肝癌细胞凋亡。
Oncol Rep. 2010 Apr;23(4):1013-9. doi: 10.3892/or_00000727.

引用本文的文献

1
The Relevance of Telomerase and Telomere-Associated Proteins in B-Acute Lymphoblastic Leukemia.端粒酶和端粒相关蛋白在 B 急性淋巴细胞白血病中的相关性。
Genes (Basel). 2023 Mar 10;14(3):691. doi: 10.3390/genes14030691.
2
Telomeres and Telomerase in the Development of Liver Cancer.端粒与端粒酶在肝癌发生发展中的作用
Cancers (Basel). 2020 Jul 24;12(8):2048. doi: 10.3390/cancers12082048.

本文引用的文献

1
Genome, Epigenome, and Transcriptome Editing via Chemical Modification of Nucleobases in Living Cells.通过对活细胞中的碱基进行化学修饰来进行基因组、表观基因组和转录组编辑。
Biochemistry. 2019 Feb 5;58(5):330-335. doi: 10.1021/acs.biochem.8b00958. Epub 2018 Dec 12.
2
Transcriptomic analysis of hepatocellular carcinoma reveals molecular features of disease progression and tumor immune biology.肝细胞癌的转录组分析揭示了疾病进展和肿瘤免疫生物学的分子特征。
NPJ Precis Oncol. 2018 Nov 15;2:25. doi: 10.1038/s41698-018-0068-8. eCollection 2018.
3
Telomerase reverse transcriptase suppression inhibits cell proliferation and promotes cell apoptosis in hepatocellular cancer.
端粒酶逆转录酶抑制抑制肝癌细胞增殖并促进细胞凋亡。
IUBMB Life. 2018 Jul;70(7):642-648. doi: 10.1002/iub.1758. Epub 2018 Apr 29.
4
New trials and results in systemic treatment of HCC.新的临床试验和结果在 HCC 的系统治疗中。
J Hepatol. 2018 Aug;69(2):525-533. doi: 10.1016/j.jhep.2018.03.028. Epub 2018 Apr 11.
5
Implications of TERT promoter mutations and telomerase activity in urothelial carcinogenesis.TERT 启动子突变与端粒酶活性在尿路上皮肿瘤发生中的意义。
Nat Rev Urol. 2018 Jun;15(6):386-393. doi: 10.1038/s41585-018-0001-5.
6
Short Telomeres Induce p53 and Autophagy and Modulate Age-Associated Changes in Cardiac Progenitor Cell Fate.端粒较短会诱导 p53 和自噬,并调节与年龄相关的心脏祖细胞命运变化。
Stem Cells. 2018 Jun;36(6):868-880. doi: 10.1002/stem.2793. Epub 2018 Feb 25.
7
In-depth proteomic analysis of tissue interstitial fluid for hepatocellular carcinoma serum biomarker discovery.用于发现肝细胞癌血清生物标志物的组织间质液深度蛋白质组学分析。
Br J Cancer. 2017 Nov 21;117(11):1676-1684. doi: 10.1038/bjc.2017.344. Epub 2017 Oct 12.
8
Precision medicine for hepatocellular carcinoma: driver mutations and targeted therapy.肝细胞癌的精准医学:驱动突变与靶向治疗
Oncotarget. 2017 Jun 6;8(33):55715-55730. doi: 10.18632/oncotarget.18382. eCollection 2017 Aug 15.
9
Effect of TERT on the growth of fibrosarcoma via caspase-3, survivin and PKB.端粒酶逆转录酶(TERT)通过半胱天冬酶-3、生存素和蛋白激酶B对纤维肉瘤生长的影响。
Oncol Lett. 2017 Aug;14(2):1939-1942. doi: 10.3892/ol.2017.6373. Epub 2017 Jun 13.
10
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator.锌指和BTB结构域蛋白48(ZBTB48)既是一种脊椎动物端粒结合蛋白,也是一种转录激活因子。
EMBO Rep. 2017 Jun;18(6):929-946. doi: 10.15252/embr.201744095. Epub 2017 May 12.